Stockscreener 앱 받기
42.66
0.95%
0.40
시장 영업 전:
42.80
0.14
+0.33%
전일 마감가:
$42.26
열려 있는:
$42.95
하루 거래량:
972.99K
Relative Volume:
0.92
시가총액:
$2.65B
수익:
-
순이익/손실:
$-229.97M
주가수익비율:
-9.8672
EPS:
-4.3234
순현금흐름:
$-136.51M
1주 성능:
-6.10%
1개월 성능:
+5.00%
6개월 성능:
+139.26%
1년 성능:
+767.07%
1일 변동 폭
$42.25
$44.40
1주일 범위
$41.89
$46.59
52주 변동 폭
$2.8101
$47.84
Kodiak Sciences Inc Stock (KOD) Company Profile
명칭
Kodiak Sciences Inc
전화
650-281-0850
주소
1250 PAGE MILL RD, PALO ALTO, CA
Compare KOD vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
42.66 | 2.65B | 0 | -229.97M | -136.51M | -4.3234 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-09-22 | 개시 | Jefferies | Buy |
| 2025-08-14 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-12-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-05 | 개시 | H.C. Wainwright | Neutral |
| 2023-12-11 | 재개 | Goldman | Sell |
| 2023-11-17 | 업그레이드 | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-07-24 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-15 | 개시 | CapitalOne | Overweight |
| 2022-08-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-02-24 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2021-03-12 | 개시 | Evercore ISI | Outperform |
| 2021-03-01 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2021-02-17 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-01-25 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-11 | 개시 | Citigroup | Neutral |
| 2020-11-30 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-11-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-03 | 개시 | Goldman | Buy |
| 2020-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-02-06 | 개시 | SunTrust | Buy |
| 2020-01-08 | 개시 | ROTH Capital | Buy |
| 2020-01-03 | 개시 | Jefferies | Buy |
| 2019-12-24 | 개시 | JP Morgan | Overweight |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-20 | 개시 | Chardan Capital Markets | Buy |
| 2018-10-29 | 개시 | Barclays | Overweight |
| 2018-10-29 | 개시 | BofA/Merrill | Buy |
| 2018-10-29 | 개시 | Morgan Stanley | Overweight |
모두보기
Kodiak Sciences Inc 주식(KOD)의 최신 뉴스
Kodiak Sciences (KOD) up 2% since last earnings report: Can it continue? - MSN
Kodiak Sciences Inc. $KOD Stock Holdings Decreased by RIA Advisory Group LLC - MarketBeat
Eye drug data from Taiwan cohort backs Kodiak Phase 3 expansion - Stock Titan
Kodiak Sciences Presents Pipeline Advances and KSI-101 Clinical Data At Scientific Conferences - marketscreener.com
Kodiak Sciences stock is surging Friday: What's driving the action? - MSN
Kodiak Sciences (KOD) Up 2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
US stocks: Kodiak Sciences shares soar 68% after eye drug succeeds in late-stage study - MSN
Kodiak Q4 loss wider than expected, pipeline development in focus - MSN
Diabetic Retinopathy Pipeline Set for Transformational Breakthroughs by 2026 with 55+ Therapies expanding Clinical Innovation from Kodiak Sciences, Regenxbio, Adverum Biotechnologies | DelveInsight - Barchart.com
Diabetic Retinopathy Pipeline Set for Transformational - openPR.com
BlackRock (KOD) holds 3.27M shares, a 5.3% stake in Kodiak Sciences (KOD) - Stock Titan
Kodiak climbs on late-stage trial win for diabetic retinopathy therapy - MSN
Kodiak Sciences Reports Positive Trial Results for Diabetic Retinopathy - HarianBasis.co
Kodiak Sciences Inc (KOD): What’s the Chance of Success for Zenkuda? - Insider Monkey
KOD Kodiak Sciences Inc reports narrow Q4 2025 EPS beat, shares drop 3.74 percent on weak investor sentiment.Viral Trade Signals - Xã Thanh Hà
[ARS] Kodiak Sciences Inc. SEC Filing - Stock Titan
Executive pay and 2026 director vote at Kodiak Sciences (NASDAQ: KOD) - Stock Titan
Is Kodiak Sciences (KOD) stock stronger than industry leaders (-1.28%) 2026-04-22Diversification - Cổng thông tin điện tử tỉnh Lào Cai
10 Best 52-Week High US Stocks to Buy - Insider Monkey
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Why Kodiak Sciences Stock Is On The Move - TipRanks
Kodiak Sciences Inc stock hits 52-week high at $46.69 By Investing.com - Investing.com Australia
Kodiak Sciences (NASDAQ:KOD) Hits New 12-Month HighWhat's Next? - MarketBeat
Kodiak Sciences Inc stock hits 52-week high at $46.69 - Investing.com
Kodiak Sciences (KOD) reports Q4 EPS of ($1.05) - MSN
Kodiak Sciences (NASDAQ:KOD) Stock Price Up 9.8%What's Next? - MarketBeat
Kodiak Sciences KOD Stock Soars On Phase 3 Win - timothysykes.com
Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers - Benzinga
Kodiak Sciences (NASDAQ: KOD) CFO exercises options, now holds 211,930 shares - Stock Titan
Kodiak Sciences (NASDAQ:KOD) Signals Behind Surge Points To Momentum - Kalkine Media
Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Up 39.8% in March - MarketBeat
Kodiak Sciences (KOD) Stock: Downtrend Signals? (Loses Ground) 2026-04-15Overvalued Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Kodiak Sciences Stock Price Drops 5.5% - National Today
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.5%Should You Sell? - MarketBeat
Kodiak Sciences shares jump on encouraging Phase 3 trial results - MSN
Why Kodiak Sciences Stock Is Surging Higher Today - TipRanks
Kodiak Sciences (KOD) climbs 75% on stellar clinical results - MSN
Kodiak Sciences stock hits 52-week high at $45.73 By Investing.com - Investing.com Australia
Kodiak Sciences Stock Soars to New 52-Week High - National Today
Kodiak Sciences Inc (KOD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):